Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin Ohri

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Hepatology International|August 3, 2019
Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinomaYifei Zhang, N Patrik Brodin, Nitin Ohri, et al.
Radiation Oncology (London, England)|May 9, 2020
Evaluating dosimetric constraints for carbon ion radiotherapy in the treatment of locally advanced pancreatic cancerLien-Chun Lin, Guo-Liang Jiang, Nitin Ohri, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
<sup>18</sup>F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerNitin Ohri, William R Bodner, Balazs Halmos, et al.
Journal of Contemporary Brachytherapy|January 30, 2014
Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysisMichael B Bernstein, Nitin Ohri, James W Hodge, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2014
Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancerNitin Ohri, Bilal Piperdi, Madhur K Garg, et al.
The British Journal of Radiology|December 13, 2016
Fractionated stereotactic radiation therapy for brain metastases: a systematic review with tumour control probability modellingSujith Baliga, Madhur K Garg, Jana Fox, et al.
Journal of the American Academy of Dermatology|November 16, 2024
Cutaneous adverse events of osimertinib in diverse patient populations with epidermal growth factor receptor-mutated non-small cell lung cancer: A retrospective cohort analysisDaniel S Alicea, Emily Miao, Peter Ch'en, et al.
Journal of Gastrointestinal Cancer|November 3, 2019
The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic CancerMichael Shusterman, Erin Jou, Andreas Kaubisch, et al.
Clinical and Translational Radiation Oncology|April 14, 2021
The effect of low-dose radiation spillage during stereotactic radiosurgery for brain metastases on the development of de novo metastasesShiby Paul, Nitin Ohri, Christian Velten, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2019
In Reply to Klement et alNitin Ohri, Wolfgang A Tomé, Alejandra Méndez Romero, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Hepatology International|August 3, 2019
Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinomaYifei Zhang, N Patrik Brodin, Nitin Ohri, et al.
Radiation Oncology (London, England)|May 9, 2020
Evaluating dosimetric constraints for carbon ion radiotherapy in the treatment of locally advanced pancreatic cancerLien-Chun Lin, Guo-Liang Jiang, Nitin Ohri, et al.
International Journal of Radiation Oncology, Biology, Physics|January 10, 2017
<sup>18</sup>F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung CancerNitin Ohri, William R Bodner, Balazs Halmos, et al.
Journal of Contemporary Brachytherapy|January 30, 2014
Prostate-specific antigen bounce predicts for a favorable prognosis following brachytherapy: a meta-analysisMichael B Bernstein, Nitin Ohri, James W Hodge, et al.
Lung Cancer (Amsterdam, Netherlands)|December 4, 2014
Pre-treatment FDG-PET predicts the site of in-field progression following concurrent chemoradiotherapy for stage III non-small cell lung cancerNitin Ohri, Bilal Piperdi, Madhur K Garg, et al.
The British Journal of Radiology|December 13, 2016
Fractionated stereotactic radiation therapy for brain metastases: a systematic review with tumour control probability modellingSujith Baliga, Madhur K Garg, Jana Fox, et al.
Journal of the American Academy of Dermatology|November 16, 2024
Cutaneous adverse events of osimertinib in diverse patient populations with epidermal growth factor receptor-mutated non-small cell lung cancer: A retrospective cohort analysisDaniel S Alicea, Emily Miao, Peter Ch'en, et al.
Journal of Gastrointestinal Cancer|November 3, 2019
The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic CancerMichael Shusterman, Erin Jou, Andreas Kaubisch, et al.
Clinical and Translational Radiation Oncology|April 14, 2021
The effect of low-dose radiation spillage during stereotactic radiosurgery for brain metastases on the development of de novo metastasesShiby Paul, Nitin Ohri, Christian Velten, et al.
International Journal of Radiation Oncology, Biology, Physics|November 20, 2019
In Reply to Klement et alNitin Ohri, Wolfgang A Tomé, Alejandra Méndez Romero, et al.
Pageof 13